Excretion of sweat and urine pyridinoline crosslinks in healthy controls and subjects with established metabolic bone disease

Clinical Chemistry and Laboratory Medicine

Volumn 39, Issue 3, 2001, Pages 223-228

  Sarno, M ^a   Sarno, L ^a   Baylink, D ^a   Drinkwater, B ^a   Farley, S ^a   Kleerekoper, M ^a   Lang, R ^a   Lappe, J ^a   Licata, A ^a   McClung, M ^a   Miller, P ^a   Nattrass, S ^a   Recker, R ^a   Schwartz, E N ^a   Tucci, J R ^a   Wolf, S ^a   Powell, H ^a   Tjersland, G ^a   Russell Warnick, G ^a  

^a Vision Biotechnology Consulting   (United States)

Author keywords

Bone markers; Enzyme immunoassay; Pyridinoline crosslinks

Indexed keywords

ALENDRONIC ACID; BIOCHEMICAL MARKER; ESTROGEN; PYRIDINOLINE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE TURNOVER; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CROSS LINKING; ENZYME IMMUNOASSAY; ESTROGEN THERAPY; FEMALE; HUMAN; HYPERPARATHYROIDISM; MAJOR CLINICAL STUDY; MALE; METABOLIC BONE DISEASE; MICTURITION; MONITORING; OSTEOLYSIS; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; SAMPLING; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SWEAT; TECHNIQUE; URINARY EXCRETION;

ADULT; AGED; ALENDRONATE; AMINO ACIDS; AREA UNDER CURVE; BIOLOGICAL MARKERS; BONE DISEASES, METABOLIC; CROSS-LINKING REAGENTS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; HYPERPARATHYROIDISM; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; ROC CURVE; SWEAT;

EID: 17744383983     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2001.035     Document Type: Article

References (21)

1. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis
2. Biochemical markers of bone resorption compared with estimates of bone resorption from radiotracer kinetic studies in osteoporosis
3. Bisphosphonate whole body retention test: Relations to bone mineralization rate, renal function and bone mineral content in osteoporosis and metabolic bone disorders
4. Clinical usefulness of markers of bone remodelling in osteoporosis
5. Biochemical markers of bone remodeling
6. Biochemical markers of bone turnover: An update
7. Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography
8. Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography
9. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment
10. Urinary excretion of pyridinium crosslinks: A new marker of bone resorption in metabolic bone disease
11. Urinary pyridinium crosslinks of collagen: Specific markers of bone resorption in metabolic bone disease
12. Monoclonal antibody assay for free urinary pyridinium cross-links
13. Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption
14. A collection method and high-sensitivity enzyme immunoassay for sweat pyridinoline and deoxypyridinoline crosslinks
15. A method of comparing the areas under receiver operating characteristic curves derived from the same cases
16. Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine
17. The renal clearance of free and conjugated pyridinium cross-links of collagen
18. Automated on-line solid-phase extraction and high-performance liquid chromatographic analysis of total and free pyridinium crosslinks in serum
19. Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion
20. Bone turnover marker response to treatment of Paget's disease with pamidronate
21. Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease